Core Viewpoint - The successful IPOs of Zhipu and Jingfeng Medical represent significant milestones in China's AGI and surgical robotics sectors, showcasing the effectiveness of the "Patience Capital Beijing Model" through collaboration between state-backed funds and market-oriented investment institutions [4][17]. Group 1: Zhipu's Journey - Zhipu, the first publicly listed company in China focused on AGI, achieved a market capitalization of HKD 528 billion on its listing day, with an opening price of HKD 120 per share [3]. - Founded by a team from Tsinghua University, Zhipu began its journey in 2019, aiming to develop AI that can think like humans, despite initial skepticism about AGI's commercial viability [7][8]. - The company has developed the GLM series of models, with its flagship GLM-4.5 achieving a score of 63.2 in 12 global benchmark tests, ranking first in China and third globally [10]. - Zhipu's success is attributed to strategic investments from Junlian Capital and the Social Security Fund, which provided not only financial support but also strategic guidance throughout its growth phases [9][11]. Group 2: Jingfeng Medical's Breakthrough - Jingfeng Medical, a leader in surgical robotics, successfully listed on the Hong Kong Stock Exchange with an opening price of HKD 59 per share and a market capitalization of HKD 230 billion [4]. - Founded in 2017, Jingfeng Medical aimed to break the monopoly of the Da Vinci system in the surgical robot market, achieving significant milestones such as the approval of its multi-port laparoscopic surgical robot in 2022 [13]. - The company has established itself as a leader in the domestic market, selling 20 surgical robots in China in 2024, and has completed over 14,000 robot-assisted surgeries by mid-2025 [15]. Group 3: Patience Capital Beijing Model - The simultaneous IPOs of Zhipu and Jingfeng Medical highlight the effectiveness of the Social Security Fund's innovative mechanism, demonstrating the successful collaboration between state-level patience capital and market-oriented investment [17]. - Since its establishment, the Social Security Fund has invested 60% of its funds in Beijing, with nearly 40% of its portfolio companies receiving national awards or participating in major national projects [17]. - Junlian Capital has invested in 19 projects across various cutting-edge technology fields, emphasizing the importance of transforming technological advancements into sustainable economic value [18].

将投中网设为"星标⭐"，第一时间收获最新推送 耐心资本，将成为股权投资推动科技创新的一个关键力量。 整理丨 黎曼 来源丨 投中网 从美元到人民币，从民营资本到国有资本，这些一级市场的变化都说明世界变了，行业、产业底层逻辑在变。在这个大背景下， GP 们该如何找到自己 在未来战场的打法，变得至关重要。 以下为 君联资本总裁李家庆的现场演讲实录： 尊敬的各位来宾，大家好，我本次演讲主题为《耐心资本的"北京模式"投资实践》。 去年以来，耐心资本在不同场合被多次提及，它不再只是一个口号，一种理念，而是走深走实，成为股权投资推动科技创新的一个关键力量。今天在场 有各种不同类型的耐心资本，大家共同分享交流、共话北京模式，君联资本作为长期坚持科技创新投资的本土机构，也作为耐心资本——社保基金中关 村自主创新专项基金的管理人，很高兴和大家分享我们的思考与实践。 当前，国际政治、经济格局发生深刻变革。 中国经济发展也正在经历"范式变化"：科技创新成为重要驱动力，重新塑造增长的底层逻辑。 在一级市场发展了 25 年的君联资本总裁李家庆直截了当的指出：我们要认清现实，市场底层逻辑发生了变化，要坚持市场化、专业化的基本立足点。 20 ...

将投中网设为"星标⭐"，第一时间收获最新推送 来源丨 投中网 这两年，通过政府主导的产业投资案例越发出圈，也形成了各地独特的模式，如＂合肥模式＂、＂深圳模式＂，＂杭州模式＂等。 其实作为科研、产业、政策响应前沿的首都北京，也早已形成了"耐心资本北京模式"。 在中关村新一轮先行先试改革任务中，北京率先提出了"引导社保基金、保险资金等开展对科技创新领域的长期投资"。 2023 年 7 月，全国社会保障 基金理事会与北京市进一步深化合作，设立了社保基金中关村自主创新专项基金（君联资本担任管理人），首期规模 50 亿元，专项基金期限超过 10 年，全力支持北京科创企业自主创新，为其提供长期稳定的资金支持。 2023 年 -2024 年，北京市设立总规模 1000 亿元的八支市级政府投资基金，采取 Co-GP 的管理模式，遴选国内市场化专业化投资机构开展深度合 作，依托 " 资本 + 政策 " 的配套措施，助力资本与产业深度融合。 这种"政府顶层设计 + 市场化专业化运营管理 + 链主企业及产业集群带动 " 的创新探索，结合北京首都的独特优势，正在加速形成"耐心资本北京模 式"。在这类耐心资本的支持下，目前北京已跑出了 ...